MedsFacts Meta-Analysis covering adverse side effect reports of BUMETANIDE 1.5MG patients who developed METABOLIC ACIDOSIS.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking BUMETANIDE 1.5MG reported METABOLIC ACIDOSIS to the FDA. A total of 1 BUMETANIDE 1.5MG drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between BUMETANIDE 1.5MG and METABOLIC ACIDOSIS. In doing so, we compare BUMETANIDE 1.5MG with other drugs that cause METABOLIC ACIDOSIS, to help you evaluate whether or not BUMETANIDE 1.5MG causes METABOLIC ACIDOSIS. Likewise, this page shows the most highly-reported side effects of BUMETANIDE 1.5MG, so you can see if METABOLIC ACIDOSIS ranks among BUMETANIDE 1.5MG's most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for BUMETANIDE 1.5MG and METABOLIC ACIDOSIS, such as the raw number and percentage of patients in FDA reports who used BUMETANIDE 1.5MG and developed METABOLIC ACIDOSIS. Next, the Dashboard lists the most common reasons (indications) why BUMETANIDE 1.5MG was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of BUMETANIDE 1.5MG. This pie-chart summarizes, for all FDA reports covering BUMETANIDE 1.5MG, whether or not the treating physician felt BUMETANIDE 1.5MG (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering BUMETANIDE 1.5MG. You may click on any of these side effects to learn more about them, in general, or specifically for BUMETANIDE 1.5MG. Finally, we identify the drugs most widely associated with BUMETANIDE 1.5MG in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of BUMETANIDE 1.5MG causing METABOLIC ACIDOSIS: 1
Reports of any side effect of BUMETANIDE 1.5MG : 1
Percentage of BUMETANIDE 1.5MG patients where METABOLIC ACIDOSIS is a reported side effect: 100%
FDA reports of any drug causing METABOLIC ACIDOSIS : 9265
Average percentage for all medicated patients where METABOLIC ACIDOSIS is reported as a complication: 0.058067550768369%
Most frequent diagnoses/indications for prescribing BUMETANIDE 1.5MG:
( 0 patients )
Physician opinion on BUMETANIDE 1.5MG as adverse event culprit:
Most common side effects for patients taking BUMETANIDE 1.5MG:
ACIDOSIS (1 patients)
MITRAL VALVE INCOMPETENCE (1 patients)
METABOLIC ACIDOSIS (1 patients)
HYPOVOLAEMIA (1 patients)
HYPOTENSION (1 patients)
HYPOPHAGIA (1 patients)
HYPERKALAEMIA (1 patients)
HAEMODIALYSIS (1 patients)
EJECTION FRACTION DECREASED (1 patients)
DRUG INTERACTION (1 patients)
Twitter feed for BUMETANIDE 1.5MG - Pending/Beta
Drugs with high reportage of METABOLIC ACIDOSIS:
HEPARIN SODIUM INJECTION (1279 patients)
ASPIRIN (833 patients)
ACETAMINOPHEN (760 patients)
METFORMIN HCL (645 patients)
FUROSEMIDE (442 patients)
LASIX (434 patients)
IBUPROFEN (427 patients)
LISINOPRIL (390 patients)
SEROQUEL (348 patients)
ALLOPURINOL (337 patients)
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.